- Enphase Energy Inc (ENPH): 3.19%
- RingCentral Inc Class A (RNG): 2.76%
- Align Technology Inc (ALGN): 2.71%
- Bristol-Myers Squibb Co (BMY): 2.71%
- Merck & Co Inc (MRK): 2.68%
- Cirrus Logic Inc (CRUS): 2.56%
- BioMarin Pharmaceutical Inc (BMRN): 2.52%
- Jazz Pharmaceuticals PLC (JAZZ): 2.52%
- F5 Inc (FFIV): 2.50%
- Pfizer Inc (PFE): 2.39%
INVN ETF — Holdings & Analysis
Alger Russell Innovation ETF (INVN) is an equity ETF managed by Alger, focusing on U.S. companies deemed innovative and underrecognized by the market.
Launched in January 2025, INVN has a small AUM of $0.02 billion and an expense ratio of 0.55%. The fund aims to capture growth from companies developing or benefiting from new technologies and advancements, differentiating itself through its specific focus on unrecognized innovation within the Russell index. Past performance does not guarantee future results.
Alger Russell Innovation ETF (INVN) ETF — Price, Holdings & Analysis
ETF 개요
위험 지표
운용보수율
주요 보유 종목
펀드는 어떻게 배분되어 있나요?
- 기타: 0.1%
- 미국: 95.9%
- 아일랜드: 2.1%
- 호주: 1.9%
배당수익률
- State Street Technology Select Sector SPDR ETF (XLK) — 비용 비율 0.08%
- State Street Financial Select Sector SPDR ETF (XLF) — 비용 비율 0.08%
- State Street Energy Select Sector SPDR ETF (XLE) — 비용 비율 0.08%
- iShares Russell 2000 ETF (IWM) — 비용 비율 0.19%
- iShares MSCI EAFE ETF (EFA) — 비용 비율 0.32%
- Invesco QQQ Trust, Series 1 (QQQ) — 비용 비율 0.18%
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 비용 비율 0.16%
- AdvisorShares Vice ETF (VICE) — 비용 비율 1.71%
위험 지표
- 베타: 0.00
질문 및 답변
What is INVN and what does it track?
Alger Russell Innovation ETF (INVN) is an actively managed equity ETF that seeks to track the performance of the Russell Innovation Index. This index is composed of U.S. equity securities that Alger believes represent innovative companies the market has not yet fully recognized. These companies are typically involved in developing or benefiting from new products, services, technologies, or advancements. The fund invests at least 80% of its assets in these securities, providing investors with targeted exposure to potentially high-growth, innovative businesses.
What is the expense ratio for INVN?
The expense ratio for INVN is 0.55%. This means that for every $10,000 invested, $55 is deducted annually to cover the fund's operating expenses. While this is a reasonable expense ratio for an actively managed ETF focusing on a specific investment strategy, it is important for investors to consider this cost when evaluating the fund's potential returns. Investors should compare INVN's expense ratio to those of similar ETFs to assess its cost-effectiveness.
What are the top holdings in INVN?
As of 2026-03-15, the top holdings in INVN include Enphase Energy Inc (ENPH) at 3.19%, RingCentral Inc Class A (RNG) at 2.76%, and Align Technology Inc (ALGN) at 2.71%. These holdings reflect the fund's focus on innovative companies within the technology and healthcare sectors. Bristol-Myers Squibb Co (BMY) and Merck & Co Inc (MRK) are also top holdings, both at 2.71% and 2.68% respectively. The fund's concentrated portfolio means the performance of these top holdings will significantly impact the overall performance of the ETF.
Is INVN a good long-term investment?
Whether INVN is a good long-term investment depends on an individual investor's risk tolerance, investment goals, and time horizon. The fund focuses on innovative companies, which can offer high growth potential but also carry higher risk. INVN's expense ratio of 0.55% should be factored into long-term return expectations. Investors should carefully consider the fund's investment strategy, holdings, and risk profile in relation to their own financial circumstances before making a decision. Past performance does not guarantee future results.
How does INVN compare to similar ETFs?
INVN distinguishes itself through its focus on unrecognized innovation within the Russell index. With an expense ratio of 0.55% and AUM of $0.02 billion, it is smaller than some of its competitors. Other innovation-focused ETFs may have different investment strategies, sector allocations, or expense ratios. Investors should compare INVN's holdings, performance, and risk metrics to those of other similar ETFs to determine which fund best aligns with their investment objectives. Past performance does not guarantee future results.
Does INVN pay dividends?
According to the latest data, INVN has a dividend yield of 0.00%. This indicates that the fund does not currently distribute any dividends to its shareholders. Investors seeking income-generating investments may want to consider other ETFs that offer higher dividend yields. The fund's focus is primarily on capital appreciation through investments in innovative companies, rather than dividend income.